Searchable abstracts of presentations at key conferences in endocrinology

ea0029p666 | Diabetes | ICEECE2012

Treating depression in type 2 diabetic patients improves depressive symptoms and quality of life but not metabolic control

Nicolau Ramis J. , Frances Artigas C. , Rivera Irigoin R. , Olivares Alcolea J. , Gil Palmer A. , Gomez Gomez L. , Rodriguez Rodriguez I. , Chacartegui Quetglas B. , Quevedo Juanals J. , Masmiquel Comas L.

Introduction:Type 2 Diabetes (T2DM) almost doubles the risk of comorbid depression, with lifetime prevalence up to 29%. It is important to recognize and treat depression in T2DM because its association with hyperglycemia, increased diabetic complications and poor quality of life (QoL) is well established. However, currently available medical therapy for depression is effective in reducing depressive symptoms, but does not consistently improves HbA1c levels. Aims:Determine the ...